Merck’s COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDA
MONDAY, Nov. 29, 2021 (HealthDay News) — Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration. On Friday morning Merck announced updated results from its molnupiravir study that showedContinue Reading